Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
The number of consultations and fees per consultation, the number of examinations, and the number of rental contracts increased due to improvements in clinical techniques, stronger recruitment and training of veterinarians, expanded medical equipment, a review of consultation workflows, price revisions, improved service quality, and stronger sales efforts.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥6,192 million (YoY +17.3%) |
| Operating profit | ¥1,150 million (YoY +59.5%) |
| Ordinary income | ¥1,142 million (YoY +58.6%) |
| Profit attributable to owners of the parent | ¥833 million (YoY +60.0%) |
| Net income per share | ¥64.48 |
| Operating Margin | 18.6% |
| Equity ratio | End of the current fiscal period 43.1 % / End of previous period 47.4 % |
| Total assets | ¥11,313 million |
| Net assets | ¥4,881 million |
| Cash flows from operating activities | ¥1,395 million |
| Cash flows from investing activities | ¥-2,486 million |
| Cash flows from financing activities | ¥1,575 million |
| Cash and cash equivalents at end of period | ¥1,592 million |
| Full-year earnings forecast | Net Sales ¥6,600 million (YoY +6.6%) / Operating profit ¥1,270 million (YoY +10.4%) / Ordinary income ¥1,220 million (YoY +6.8%) / Profit attributable to owners of the parent ¥890 million (YoY +6.8%) |
| Annual Dividend Forecast | ¥12 → ¥13（+8.3%） |
| Payout ratio | Current fiscal year 19.6 % / Next-year forecast 19.9 % |
| Shareholder Return Policy | Consolidated dividend payout ratio of at least 20% and stable increases in returns of profits to shareholders |
| Depreciation and amortization | ¥568,295 thousand |
| Impairment loss | Not applicable (impairment losses on fixed assets by reporting segment for the consolidated fiscal year) |
| Breakdown of extraordinary income (loss) | Extraordinary income None / Extraordinary loss None |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name None |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 14,391,000 |
| Treasury Shares at Period-End | 1,466,540 |
| Factors Behind Changes in Business Performance | The number of consultations and fees per consultation, the number of examinations, and the number of rental contracts increased due to improvements in clinical techniques, stronger recruitment and training of veterinarians, expanded medical equipment, a review of consultation workflows, price revisions, improved service quality, and stronger sales efforts. |
Items this document does not state (5)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.As demand exceeded consultation capacity, capacity expanded through improvements in clinical techniques, stronger recruitment and training of veterinarians, expanded medical equipment, and a review of consultation workflows. In addition, the number of consultations increased even after the price revisions, while the number of examinations and rental contracts in diagnostic imaging and home care also increased as a result of improved service quality and stronger sales efforts.